8-K 1 v130102_8k.htm
Washington, D.C. 20549
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 29, 2008
 
VNUS Medical Technologies, Inc.
(Exact name of registrant as specified in its charter)

Delaware
000-50988
94-3216535
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification Number)
 
5799 Fontanoso Way
San Jose, California 95138
(408) 360-7200
 
(Address of principal executive offices including zip code and registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
     On October 29, 2008, VNUS Medical Technologies, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter of 2008. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

     The information in this Item 2.02 of this Current Report on Form 8-K and the information contained in the press release referenced herein shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 of this Current Report on Form 8-K and the press release referenced herein is not incorporated by reference into any filings of VNUS, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing, unless explicitly incorporated by specific reference into such filing.
 
Item 9.01 Financial Statements and Exhibits.
 
     (d) Exhibits

Exhibit
No.
 
Description
 
 
 
99.1
 
Press Release of VNUS Medical Technologies, Inc., dated October 29, 2008 entitled “VNUS Medical Technologies Reports Third-Quarter 2008 Results”
 
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: October 29, 2008

 
VNUS MEDICAL TECHNOLOGIES, INC.
  By: 
 /s/ Peter Osborne
 
Name:
Peter Osborne
 
Title:
Chief Financial Officer and Vice President of Finance & Administration

 
 
 
 
THE CURRENT REPORT ON FORM 8-K DATED OCTOBER 29, 2008

Exhibit
 
Description
 
 
 
99.1
 
Press Release of VNUS Medical Technologies, Inc., dated October 29, 2008 entitled, “VNUS Medical Technologies Reports Third-Quarter 2008 Results”